Semaglutide vs Phentermine for Weight Loss: Key Differences

You have probably seen both options discussed in weight loss conversations: phentermine, a stimulant medication prescribed for years, and semaglutide, a newer GLP-1 medication that has become widely discussed. Both reduce appetite. Both can support weight loss. But they work in fundamentally different ways, produce very different results, and are designed for very different treatment timelines.

If you are comparing these options, here is what the evidence actually shows.

What phentermine is

Phentermine is a sympathomimetic amine, a Schedule IV controlled substance first approved by the FDA in 1959. It is one of the longest-prescribed weight loss medications in the United States.

Phentermine works as a central nervous system stimulant. It increases the release of norepinephrine and dopamine in your brain, which suppresses appetite and increases wakefulness and energy. It is approved only for short-term weight management, typically 3 to 12 weeks.

Because phentermine is a controlled substance, it requires a prescription from a licensed provider and is subject to state-specific prescribing regulations. It is available as a generic medication and is relatively inexpensive (typically $15 to $40 per month).

Phentermine is often combined with topiramate (a medication sold under the brand name Qsymia) to extend its use beyond the short-term window.

What semaglutide is

Semaglutide is a GLP-1 receptor agonist, an engineered peptide that mimics the glucagon-like peptide-1 hormone naturally produced in your gut.

Semaglutide was used for type 2 diabetes in 2017 and for chronic weight management in 2021. It is designed for long-term, ongoing use, not short-term appetite suppression.

Semaglutide is available as a brand-name injectable or oral medication (cost: $1,000 to $1,500/month without insurance) or as a compounded medication from licensed pharmacies (cost: $249/month all-inclusive at Transformation Health).

Phentermine is not offered at Transformation Health. This comparison is informational, designed to help you understand how the two approaches differ.

How they work: side-by-side comparison

What the evidence shows: weight loss

Phentermine: Clinical trials in short-term studies (usually 12 weeks) show weight loss of 3 to 5 percent above placebo^[1]. This typically translates to 6 to 15 pounds for someone starting at 200 pounds, depending on baseline weight and compliance.

Semaglutide: The STEP 1 trial, published in the New England Journal of Medicine in 2021, included 1,961 participants followed for 68 weeks. Mean weight reduction was 14.9 percent of baseline body weight^[2]. For someone weighing 200 pounds, that is approximately 30 pounds. This magnitude is substantially larger than what phentermine produces in short-term use.

Phentermine works quickly but produces modest results over a limited timeframe. Semaglutide works more slowly but produces large, sustained results over months.

Side effects and tolerability

Phentermine side effects (stimulant-related):

• Elevated heart rate and blood pressure
• Insomnia and sleep disruption
• Nervousness or anxiety
• Dry mouth
• Tremor or jitteriness
• Not appropriate for patients with certain cardiac conditions, uncontrolled hypertension, or psychiatric conditions

Semaglutide side effects (gastrointestinal):

• Nausea, especially in the first 1 to 2 weeks at each dose level
• Constipation (common)
• Diarrhea or loose stools (less common)
• Reduced appetite (intended effect)
• Generally well-tolerated; GI side effects often diminish with time

Phentermine is not suitable for patients with cardiac concerns or those sensitive to stimulants. Semaglutide is not suitable for patients with personal or family history of medullary thyroid cancer or certain pancreatic conditions. Most patients tolerate one or the other better based on their medical history and side effect sensitivity.

Key differences: duration of treatment

This is one of the most important distinctions.

Phentermine is approved and intended for short-term use only (3 to 12 weeks). Using it longer is off-label. Your provider might do this if the benefit outweighs the risks for your situation, but it is not the standard indication. The short-term nature reflects how stimulants work: effectiveness often declines with time as your body adapts.

Semaglutide is designed for long-term, chronic use. Many patients remain on semaglutide for months or years. The medication does not produce tolerance in the same way, and it is approved for ongoing weight management, not just a short push.

If you need appetite control for a specific event or a brief period, phentermine fits that use case. If you are working toward sustained weight loss over many months, semaglutide is the better match for how it is designed.

Controlled substance status

Phentermine is a Schedule IV controlled substance. This means:

• Prescriptions cannot be refilled as many times as non-controlled medications
• State regulations vary; some states restrict the number of refills per month
• Your provider must document that you are an appropriate candidate
• If you have a history of substance use disorder, phentermine may not be appropriate for you

Semaglutide is not a controlled substance and does not have these restrictions.

Cardiovascular outcomes

An important recent finding: the SELECT trial (2023) examined semaglutide in patients with overweight or obesity but without diabetes. The study found that semaglutide reduced the risk of major adverse cardiovascular events (heart attack, stroke, cardiovascular death) by approximately 20 percent^[3].

No comparable cardiovascular outcome trials exist for phentermine. In fact, the stimulant effects of phentermine (elevated heart rate and blood pressure) make it unsuitable for some patients with cardiac risk.

If you have cardiovascular risk factors (high blood pressure, family history of heart disease, previous cardiac events), semaglutide may be the more appropriate choice.

Cost comparison

Phentermine as a standalone medication: Generic phentermine costs $30 to $80 per month at most pharmacies without insurance and is often covered by insurance. However, this price is just for the medication. Phentermine typically requires additional expenses: separate provider visits for monitoring ($50 to $150 per visit, often every 2 to 4 weeks during treatment), and separate lab costs if your provider requests labs to monitor blood pressure and heart rate ($50 to $150 per lab panel).

A realistic 12-week phentermine treatment course looks like:

• Medication: $60 to $240
• Provider visits: $150 to $600 (3 to 6 visits over 12 weeks)
• Labs: $50 to $150
• Total: roughly $260 to $990 for 12 weeks of treatment

Brand-name semaglutide: $900 to $1,600 per month without insurance. Often not covered by insurance.

Compounded semaglutide at Transformation Health: $249 per month, all-inclusive (medication, provider care, ongoing labs, and coaching). No separate provider visit fees. No separate lab fees.

For a 6-month course:

• Compounded semaglutide: $249 × 6 = $1,494 (all-inclusive)
• Phentermine (short-term): $260 to $990 for 12 weeks, then you stop

When you account for what is actually included, the cost difference between phentermine and compounded semaglutide is much smaller than a price-per-month comparison suggests. More importantly, after 12 weeks of phentermine, you face a critical problem: what comes next?

Why phentermine is limited to 12 weeks

Phentermine’s 12-week limit is not arbitrary. It reflects the biology of how the medication works and the legal framework governing its use.

Phentermine is a Schedule IV controlled substance, classified as an amphetamine-class stimulant. The FDA approved it for short-term use only because of tolerance and dependence concerns. Here is why the timeline matters:

Tolerance develops quickly. The appetite-suppressing effects of phentermine typically begin to diminish between 4 and 12 weeks. Your body adapts to the stimulant, and the medication becomes less effective. This is why longer-term use is not FDA-approved, even off-label.

Limited mechanisms of action. Unlike semaglutide, which works through a hormonal pathway that does not produce tolerance, phentermine works through central nervous system stimulation. Stimulants inherently produce tolerance as your brain adjusts to the chemical signal.

Controlled substance regulations. Prescribing limits vary by state, but federal law restricts how often prescriptions can be refilled. Most providers will not prescribe phentermine for more than 12 weeks without strong clinical justification.

The problem after 12 weeks. When you stop phentermine, your appetite returns. Unlike semaglutide, phentermine does not address the underlying biological drivers of hunger (hormonal signaling, metabolic adaptation, food noise). You lose the appetite suppression and have not necessarily built different eating habits or learned how to manage appetite without medication.

This is why many patients who lose weight on phentermine regain it quickly after stopping. The medication suppressed appetite for 12 weeks, but the underlying biology that triggered the weight gain in the first place is still present.

Is phentermine ever prescribed beyond 12 weeks? Yes, some providers prescribe it off-label for longer durations or combine it with other medications (like topiramate under the brand name Qsymia) to extend the treatment window. This requires careful monitoring and is not standard. If you have weight loss goals that extend beyond 12 weeks, a long-term medication strategy (like semaglutide) is more aligned with the biology of sustained weight loss.

Long-term weight management: why the treatment timeline matters

Here is the practical difference between the two approaches:

Phentermine path: 12 weeks of appetite suppression, weight loss of 6 to 15 pounds, then medication stops. What comes after is up to you. If you have not changed your eating environment or built new habits in those 12 weeks, the weight typically returns. Studies show that weight regain is common and rapid after stopping phentermine.

Semaglutide path: Ongoing medication that continues to suppress appetite and improve metabolic signaling for as long as you use it. If your goal is 20, 30, or 40 pounds of weight loss, semaglutide can support that over months. The medication is designed to work long-term while you build new habits, and you can continue using it for years if needed.

The cost and timeline trade-off is real: phentermine is cheaper month-to-month but is finite. Semaglutide is more expensive month-to-month but is designed for patients with long-term weight management goals. After you account for what happens after phentermine ends, the true cost of treatment starts to become clearer.

If you have already tried phentermine in the past and the weight returned, this is why. You are not failing at diet or exercise. The medication was not designed for long-term weight management, and without an ongoing medical intervention, your body’s biological drive to regain weight (a phenomenon called metabolic adaptation) typically wins.

Who might choose phentermine

• You need short-term appetite suppression for a specific event or goal
• You want the least expensive option and are willing to try short-term treatment
• Cost is a significant barrier and you want to test whether medication-supported weight loss works for you
• Your provider recommends it as a first-line option based on your medical history
• You cannot tolerate GLP-1 medications for medical reasons
• You prefer a stimulant approach over a hormonal approach

Phentermine is a valid first-line medication. It is proven, affordable, and works quickly. The limitation is duration and magnitude of effect.

Who might choose semaglutide

• You need significant, sustained weight loss (20+ pounds)
• You have type 2 diabetes or pre-diabetes
• You have cardiovascular risk factors (high blood pressure, history of heart disease)
• You want a medication designed for long-term use without tolerance concerns
• You prefer a hormonal approach without stimulant side effects
• You have failed at weight loss with diet and exercise alone over many years

Semaglutide is designed for patients seeking substantial, durable weight loss with medical oversight.

Can you use both together?

Some providers prescribe phentermine and GLP-1 medications together off-label for patients who need additional appetite suppression. This is an individualized clinical decision based on your health history, labs, blood pressure, heart rate, and treatment goals.

If you are considering combination therapy, this requires provider oversight. Do not combine these medications on your own.

The process at Transformation Health

If you are evaluating whether semaglutide or another GLP-1 medication is appropriate for you, the process is straightforward.

You complete a brief online intake form describing your health history, current weight and height, weight loss goals, and any prior weight loss medications you have tried. An independent, licensed provider reviews your information and determines whether a GLP-1 prescription is medically appropriate for your situation.

If it is, your compounded semaglutide is prepared by a licensed US compounding pharmacy and shipped to your door within days. You receive ongoing provider support, lab work as needed, and coaching.

Pricing:

• Compounded semaglutide: $249/month injectable, $279/month oral (all-inclusive)
• Compounded tirzepatide: $339/month injectable (all-inclusive)
• Maintenance program: $199/month for patients with prior GLP-1 experience

All-inclusive means your monthly fee covers medication, provider care, lab work if needed, and coaching. No hidden fees. You can cancel anytime.

Residents of AR, DC, DE, MS, NM, RI, and WV are required by state law to complete a live video consultation with a provider before a prescription can be issued.

The takeaway

Phentermine and semaglutide both reduce appetite and support weight loss, but they are fundamentally different medications designed for different situations.

Phentermine works quickly, is inexpensive, and is appropriate for short-term appetite control. The evidence for weight loss is modest and duration is limited.

Semaglutide produces significantly greater weight loss, is designed for long-term use, and has cardiovascular outcome data supporting its use in patients with metabolic risk. The cost is higher, but so is the evidence base for results.

The choice depends on your medical situation, how much weight you need to lose, your timeline, and what side effects you can tolerate. An honest conversation with your provider about both options, what each produces, and what fits your situation will point you toward the right choice.

Citations

[1] Phentermine weight loss outcomes based on clinical trial meta-analyses. Representative meta-analyses show 3-5% additional weight loss above placebo in short-term randomized controlled trials (12 weeks).

[2] Wilding JPH, Batterham RL, Calanna S, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/

[3] Lowe WL Jr, Raj A, Börger JG, et al. “Semaglutide and Cardiovascular Outcomes in Patients with Overweight or Obesity.” New England Journal of Medicine. 2023;389(24):2221-2232. https://pubmed.ncbi.nlm.nih.gov/37952131/